Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p
Authors:
- 29 October 2019
- journal article
- research article
- Published by International Scientific Information, Inc. in Medical Science Monitor
- Vol. 25, 8095-8104
Abstract
BACKGROUND:Patients with advanced non-small cell lung cancer (NSCLC) treated with cisplatin, also termed cis-diamminedichloroplatinum (CDDP) or diamminedichloroplatinum (DDP), may develop chemoresistance. This study aimed to investigate the role of l...Keywords
This publication has 24 references indexed in Scilit:
- The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signalingMolecular Cancer, 2017
- LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIKOncotarget, 2016
- New and emerging targeted treatments in advanced non-small-cell lung cancerThe Lancet, 2016
- MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 geneCancer Letters, 2015
- Targeting of miR34a–NOTCH1 Axis Reduced Breast Cancer Stemness and ChemoresistanceCancer Research, 2014
- MiR-204 inhibits human NSCLC metastasis through suppression of NUAK1British Journal of Cancer, 2014
- The microRNA miR-34a Inhibits Non-Small Cell Lung Cancer (NSCLC) Growth and the CD44hi Stem-Like NSCLC CellsPLOS ONE, 2014
- miR-27b targets LIMK1 to inhibit growth and invasion of NSCLC cellsMolecular and Cellular Biochemistry, 2014
- miR-205 promotes the growth, metastasis and chemoresistance of NSCLC cells by targeting PTENOncology Reports, 2013
- Regulation of miR-19 to Breast Cancer Chemoresistance Through Targeting PTENPharmaceutical Research, 2011